These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 20971060)
1. Trichosanthin affects HSV-1 replication in Hep-2 cells. He DX; Tam SC Biochem Biophys Res Commun; 2010 Nov; 402(4):670-5. PubMed ID: 20971060 [TBL] [Abstract][Full Text] [Related]
2. Conversion of trichosanthin-induced CD95 (Fas) type I into type II apoptotic signaling during Herpes simplex virus infection. He D; Yau K; He X; Shi H; Zheng Y; Tam S Mol Immunol; 2011 Sep; 48(15-16):2000-8. PubMed ID: 21723610 [TBL] [Abstract][Full Text] [Related]
3. The anti-herpetic activity of trichosanthin via the nuclear factor-κB and p53 pathways. He D; Zheng Y; Tam S Life Sci; 2012 May; 90(17-18):673-81. PubMed ID: 22498878 [TBL] [Abstract][Full Text] [Related]
4. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin. Ouyang DY; Chan H; Wang YY; Huang H; Tam SC; Zheng YT Biochem Biophys Res Commun; 2006 Jan; 339(1):25-9. PubMed ID: 16289100 [TBL] [Abstract][Full Text] [Related]
5. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Huang H; Chan H; Wang YY; Ouyang DY; Zheng YT; Tam SC Life Sci; 2006 Aug; 79(13):1287-92. PubMed ID: 16725160 [TBL] [Abstract][Full Text] [Related]
6. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression. Kuo YC; Kuo YH; Lin YL; Tsai WJ Antiviral Res; 2006 Jul; 70(3):112-20. PubMed ID: 16540181 [TBL] [Abstract][Full Text] [Related]
7. [Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice]. Chen GF; Huang WG; Chen FY; Shan JL Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):239-41. PubMed ID: 16787600 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Popik W; Pitha PM Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218 [TBL] [Abstract][Full Text] [Related]
10. Enhanced apoptotic action of trichosanthin in HIV-1 infected cells. Wang YY; Ouyang DY; Huang H; Chan H; Tam SC; Zheng YT Biochem Biophys Res Commun; 2005 Jun; 331(4):1075-80. PubMed ID: 15882987 [TBL] [Abstract][Full Text] [Related]
11. Anti-HSV activity of digitoxin and its possible mechanisms. Su CT; Hsu JT; Hsieh HP; Lin PH; Chen TC; Kao CL; Lee CN; Chang SY Antiviral Res; 2008 Jul; 79(1):62-70. PubMed ID: 18353452 [TBL] [Abstract][Full Text] [Related]
12. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector. Warden MP; Weir JP Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330 [TBL] [Abstract][Full Text] [Related]
13. A novel sorting strategy of trichosanthin for hijacking human immunodeficiency virus type 1. Zhao WL; Zhang F; Feng D; Wu J; Chen S; Sui SF Biochem Biophys Res Commun; 2009 Jul; 384(3):347-51. PubMed ID: 19409877 [TBL] [Abstract][Full Text] [Related]
14. Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon. Piroozmand A; Koyama AH; Shimada Y; Fujita M; Arakawa T; Adachi A Int J Mol Med; 2004 Oct; 14(4):641-5. PubMed ID: 15375595 [TBL] [Abstract][Full Text] [Related]
16. The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs Herpes simplex virus type 1 penetration and immediate-early protein synthesis. Souza TM; Abrantes JL; de A Epifanio R; Leite Fontes CF; Frugulhetti IC Planta Med; 2007 Mar; 73(3):200-5. PubMed ID: 17285480 [TBL] [Abstract][Full Text] [Related]
17. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Preston CM; McFarlane M Virology; 1998 Sep; 249(2):418-26. PubMed ID: 9791032 [TBL] [Abstract][Full Text] [Related]
18. The herpes simplex virus type 1 vhs-UL41 gene secures viral replication by temporarily evading apoptotic cellular response to infection: Vhs-UL41 activity might require interactions with elements of cellular mRNA degradation machinery. Barzilai A; Zivony-Elbom I; Sarid R; Noah E; Frenkel N J Virol; 2006 Jan; 80(1):505-13. PubMed ID: 16352574 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory activity of soyasaponin II on virus replication in vitro. Hayashi K; Hayashi H; Hiraoka N; Ikeshiro Y Planta Med; 1997 Apr; 63(2):102-5. PubMed ID: 9140220 [TBL] [Abstract][Full Text] [Related]
20. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy. Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]